Trial no.:
|
PACTR202203850216757 |
Date of Registration:
|
30/03/2022 |
Trial Status:
|
Registered in accordance with WHO and ICMJE standards |
|
TRIAL DESCRIPTION |
Public title
|
Single Anastomosis Sleeve Jejunal Bypass versus One Anastomosis Gastric Bypass in Treatment of Obesity and Metabolic Diseases: A Randomized Controlled Trial |
Official scientific title |
Single Anastomosis Sleeve Jejunal Bypass versus One Anastomosis Gastric Bypass in Treatment of Obesity and Metabolic Diseases: A Randomized Controlled Trial |
Brief summary describing the background
and objectives of the trial
|
Several conventional and novel methods of bariatric surgery-termed metabolic surgeries - induce long-term remission of type 2 diabetes mellitus (T2DM) and dramatically improve other metabolic syndrome, such as hyperlipidemia and hypertension, independent of the patients’ weight. Some previous studies demonstrated that these metabolic effects are not only attributable to drastic weight loss and diminished caloric intake, but also to endocrine changes that result from surgical manipulation of the gastrointestinal tract. The one anastomosis gastric bypass (OAGB) procedure was first developed by Dr Robert Rutledge from the USA in 1997, as a modification of the standard Billroth II procedure. One anastomoses gastric bypass involves making of a long narrow tube of the stomach along its right border, the lesser curvature. A loop of the small gut is brought up and hooked to this tube at about 200 cms from the start of the intestine (ligament of Treitz). Santoro’s operation is a sleeve gastrectomy with transit bipartition. The aim of the procedure is to keep pass to the duodenum to decrease nutritional deficiency and to allow endoscopic management of obstructive jaundice. To be easier, this procedure was rapidly altered to a single anastomosis sleeve ileal bypass (SASI). In this study, we shifted the anastomosis up to the jejunum to evaluate the effect of laparoscopic single anastomosis sleeve jejunal (SASJ) bypass as a treatment for morbid obesity and related co-morbidities. In addition, the effect of the SASJ procedure on nutritional deficiency was examined.
The aim of this work is to compare the outcomes of Single Anastomosis Sleeve Jejunal Bypass as a modified technique from Single Anastomosis Sleeve Ileal bypass and One Anastomosis Gastric Bypass as treatment option for morbid obesity as regard weight loss and co-morbidities resolution.
|
Type of trial |
RCT |
Acronym (If the trial has an acronym then please provide) |
|
Disease(s) or condition(s) being studied |
Digestive System,Nutritional, Metabolic, Endocrine |
Sub-Disease(s) or condition(s) being studied |
|
Purpose of the trial |
Treatment: Surgery |
Anticipated trial start date |
01/04/2022 |
Actual trial start date |
|
Anticipated date of last follow up |
31/03/2024 |
Actual Last follow-up date |
|
Anticipated target sample size (number of participants) |
68 |
Actual target sample size (number of participants) |
|
Recruitment status |
Not yet recruiting |
Publication URL |
N/A |
|